Overview

A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control

Status:
Completed

Trial end date:
2008-12-01

Target enrollment:

Participant gender:

Summary

The study compared the 24-hour spirometry profile of indacaterol with that of placebo and with tiotropium as an active control in patients with chronic obstructive pulmonary disease.

Phase:

Phase 3

Details

Lead Sponsor:

Novartis

Treatments:

Tiotropium Bromide